The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
PHOENIX, Ariz., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Breakthru Medicine emerges from stealth with the close of a $60M Series A ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...
The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...
Ketones and esters (formed when an acid reacts with an alcohol) are ubiquitous as pharmaceutical intermediates and widely used for the synthesis of drug molecules. However, both share a critical ...
Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...
A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory drugs. In the article, the researchers also describe how the same strategy can ...
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...
Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...
Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results